Kim Geurts
Kim Geurts is a Scientist in Process Research & Development within Ardena’s Enabling Chemistry team in Oss. With six years of experience at Ardena, she focuses on developing and optimizing chemical processes and translating early-stage research into robust, scalable processes suitable for further development and manufacturing.
Her work combines a strong foundation in chemistry with a practical understanding of process development and continuous improvement. In 2025, Kim obtained her Lean Green Belt, enabling her to complement her scientific responsibilities with the leadership of improvement initiatives across the organization. This perspective helps her identify opportunities to strengthen both technical processes and ways of working.
Through this combination of scientific expertise and process-focused thinking, Kim contributes to building efficient and reliable development pathways as projects progress toward scale-up and manufacturing. She holds a Master’s degree in Chemistry from Radboud University in Nijmegen, completed in 2020.
Recent Publications
Martin Broxterman
Martin Broxterman is Principal Scientist and Group Lead at Ardena Oss. He brings extensive experience across pharmaceutical R&D and manufacturing, with a strong focus on process development, manufacturing operations, and GMP facility management.
Martin joined Ardena and its predecessor organizations in 2014 as an R&D Scientist, where he developed expertise in process development and scientific problem-solving. Over the years, he has gained broad experience across both development and manufacturing environments. In his current roles as Group Lead Manufacturing and Group Lead Facility Management, he is responsible for supporting the performance, compliance, and operational readiness of Ardena’s GMP pilot plant in Oss.
Martin obtained his training in Organic Chemistry and combines scientific expertise with hands-on operational leadership in pharmaceutical development and manufacturing environments.
Jeroen Geeven
Jeroen Geeven is Head of QA for Ardena’s Drug Substance Solutions Division in Oss. He leads the Quality Assurance organization supporting innovative drug substance development and manufacturing programs across a broad range of pharmaceutical technologies.
With more than 20 years of experience, Jeroen has developed extensive expertise in GMP quality systems, regulatory compliance, and the development and manufacture of complex APIs and nanomedicines. He is recognized for his pragmatic and solution-oriented approach, helping clients address quality and compliance challenges while supporting efficient project execution. At Ardena, he works closely with internal teams and clients to ensure quality is embedded throughout the development and manufacturing lifecycle.
Jeroen is passionate about building strong partnerships and fostering a culture of quality that supports successful pharmaceutical development from early-stage programs through commercialization.
Bas Gruijters
Bas Gruijters is Director Process R&D and Manufacturing in Enabling Chemistry at Ardena. He brings more than 20 years of experience in small and complex molecule synthesis, along with over 15 years of managerial experience within the pharmaceutical industry.
Throughout his career, Bas has worked with multidisciplinary teams to develop safe and scalable manufacturing processes supporting the advancement of numerous compounds into clinical development. His expertise spans process R&D, manufacturing, and enabling chemistry within pharmaceutical development environments.
Bas obtained his PhD in Synthetic Organic Chemistry from Radboud University Nijmegen.
Giovanna Brancatelli
Giovanna Brancatelli is Principal Scientist and Scientific Director at Ardena Solid State Research in Oss. She supervises R&D projects focused on polymorph, salt, and co-crystal screening, as well as preformulation studies supporting pharmaceutical development programs.
Giovanna joined Ardena in 2015 from the Department of Chemistry at the University of Trieste, where she conducted postdoctoral research on the molecular recognition of biogenic amines in the solid state. Her expertise includes polymorphism, crystallization, organic and inorganic chemistry, supramolecular chemistry, and X-ray crystallography.
Giovanna earned her MSc degree and PhD in Chemical Sciences from the University of Messina.
Paul van Tilborg
Paul van Tilborg is a senior scientific and operational leader with over 25 years of experience in analytical sciences, CMC development, and CRO operations. As Director CRO Services at Ardena in Oss, he is responsible for building and scaling bioanalytical capabilities and leading solid-state research activities, while contributing at an executive level to API analytical sciences.
Paul has a strong track record in developing organisations, facilities, and teams with a clear focus on operational efficiency, customer value, and financial performance. At Ardena, he transformed the analytical sciences function from a small start-up operation into a fully established department supporting multiple development programmes, combining technical capability build-up with scalable, financially robust operations. He consistently drives growth by aligning scientific excellence with client needs, ensuring reliable delivery, transparency, and long-term partnerships. His approach emphasises fit-for-purpose solutions, efficient execution, and creating measurable value for customers and the organisation.
Earlier in his career at MSD (Organon/Schering-Plough), he led analytical development teams and contributed to CMC strategies, regulatory submissions, and the delivery of complex drug development programmes.
He holds a PhD in Chemistry from Utrecht University and contributes to postgraduate education through teaching in applied NMR spectroscopy.
Ariane De Ganck, PhD
Since 2019, Ariane has overseen Ardena’s drug product activities, spearheading successful integration and transformation at Ardena Pamplona and expanding the company’s capabilities to include sterile services.
With over a decade of senior management experience in CRO/CDMO sectors, Ariane excels in leading multidisciplinary teams and is dedicated to team development, fostering networks, and maintaining a customer-centric approach. Her leadership has also been instrumental in driving business development initiatives.
Prior to joining Ardena, Ariane made significant contributions to the growth of Biogazelle, a specialized CRO in RNA and DNA biomarker services.
Ariane holds a PhD in biomedical sciences, focusing on proteins and oncology